Q3 2023 13F Holders as of 30 Sep 2023
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Number of holders
-
50
-
Total 13F shares, excl. options
-
15.7M
-
Shares change
-
+1.11M
-
Total reported value, excl. options
-
$87.1M
-
Value change
-
+$6.1M
-
Number of buys
-
22
-
Number of sells
-
-18
-
Price
-
$5.56
Significant Holders of LONGBOARD PHARMACEUTICALS, INC. - Common Stock, par value $0.0001 per share (LBPH) as of Q3 2023
54 filings reported holding LBPH - LONGBOARD PHARMACEUTICALS, INC. - Common Stock, par value $0.0001 per share as of Q3 2023.
LONGBOARD PHARMACEUTICALS, INC. - Common Stock, par value $0.0001 per share (LBPH) has 50 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 15.7M shares
.
Largest 10 shareholders include Cormorant Asset Management, LP (2.35M shares), FMR LLC (2.11M shares), PRICE T ROWE ASSOCIATES INC /MD/ (1.77M shares), FARALLON CAPITAL MANAGEMENT LLC (1.56M shares), Polar Capital Holdings Plc (1M shares), Point72 Asset Management, L.P. (825K shares), BlackRock Inc. (786K shares), VANGUARD GROUP INC (781K shares), Integral Health Asset Management, LLC (760K shares), and JPMORGAN CHASE & CO (534K shares).
This table shows the top 50 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.